Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Anapass, Inc. | GCTS GCT Semiconductor Holding, Inc. | 13G/A | 17.6% | Mar 26, 2024 | 2y |
| Vida Ventures, LLC | KYTX Kyverna Therapeutics, Inc. | 13D | 11.1% | Feb 12, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | FINS Angel Oak Financial Strategies Income Term Trust | 13G/A | 10.12% | May 2, 2024 | 2y |
| F9 Investments, LLC (Single Member LLC with Thomas D. Sullivan Single Member) | LL LL Flooring Holdings, Inc. | 13D/A | 8.8% | May 2, 2024 | 2y |
| Robert Davidow | ATXI Avenue Therapeutics, Inc. | 13G/A | 2.9% | May 2, 2024 | 2y |
| Board of Directors of MetLife, Inc., as an entity | MET Metlife Inc | 13D/A | 16.2% | May 2, 2024 | 2y |
| Crestview Partners III GP, L.P. | WOW WideOpenWest, Inc. Common Stock | 13D/A | 38% | May 2, 2024 | 2y |
| River Road Asset Management, LLC | PLUS Eplus Inc | 13G/A | 4.9% | Apr 30, 2024 | 2y |
| Starboard Value LP | GDDY GoDaddy Inc. | 13D/A | 4.8% | Apr 30, 2024 | 2y |
| Saba Capital Management, L.P. | LGI Lazard Global Total Return & Income Fund Inc | 13D/A | 7.72% | Apr 30, 2024 | 2y |
| River Road Asset Management, LLC | RPC Ridgepost Capital, Inc. | 13G | 11.2% | Apr 30, 2024 | 2y |
| GILEAD SCIENCES, INC. | LKFT Lakefront Biotherapeutics NV | 13D/A | 29.9% | Apr 30, 2024 | 2y |
| IndexIQ Advisors LLC | CWI Spdr Index Shares Funds | 13G/A | 0% | Apr 30, 2024 | 2y |
| GK Investor LLC | GNK Genco Shipping & Trading Ltd | 13D/A | 5.5% | Apr 30, 2024 | 2y |
| MILLENNIUM MANAGEMENT LLC | GDRX GoodRx Holdings, Inc. | 13G | 5.1% | Apr 25, 2024 | 2y |
| Barak Matalon OR ABOVE PERSON (ENTITIES ONLY) | NGMS NeoGames S.A. Ordinary Shares | 13D/A | 0% | Apr 25, 2024 | 2y |
| D. E. Shaw & Co., L.P. | IBTA Ibotta, Inc. | 13G | 9.6% | Apr 22, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | ZURA Zura Bio Ltd | 13G | 5.1% | Apr 22, 2024 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | ZURA Zura Bio Ltd | 13G | 9.99% | Apr 22, 2024 | 2y |
| Paradigm Biocapital Advisors LP | KURA Kura Oncology, Inc. | 13G | 5.1% | Apr 22, 2024 | 2y |
| Joel Charles Sklar | ACFN Acorn Energy, Inc. | 13G | 5.7% | Apr 22, 2024 | 2y |
| Kessler Judd S | CLDI Calidi Biotherapeutics, Inc. | 13D | 5% | May 1, 2024 | 2y |
| De Lisle Partners LLP | FRD Friedman Industries Inc | 13G | 5.8% | May 1, 2024 | 2y |
| IndexIQ Advisors LLC | UUP Invesco DB US Dollar Index Bullish Fund | 13G/A | 10.5% | Apr 30, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | CMT Core Molding Technologies Inc | 13D/A | 4.45% | Apr 30, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 6.61% | Apr 30, 2024 | 2y |
| Brown-Forman Corporation | NAPA The Duckhorn Portfolio, Inc. | 13D | 21.5% | Apr 30, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | STRT Strattec Security Corp | 13D/A | 18.22% | Apr 30, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G/A | 3.53% | Apr 30, 2024 | 2y |
| Saba Capital Management, L.P. | CXH Mfs Investment Grade Municipal Trust | 13D/A | 3.85% | Apr 30, 2024 | 2y |
| Imperial Petroleum Inc. | CISS C3is Inc. | 13D/A | 67.2% | Apr 30, 2024 | 2y |
| Brookstone Capital Management | AAPR Innovator ETFs Trust | 13G | 11.82% | Apr 30, 2024 | 2y |
| Adage Capital Management, L.P. | EYPT EyePoint, Inc. | 13G/A | 9.9% | Apr 30, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | TRIB Trinity Biotech PLC | 13D/A | 26.8% | Apr 30, 2024 | 2y |
| Vivo Opportunity Fund Holdings, L.P. | SLNO Soleno Therapeutics Inc | 13D/A | 22.5% | Apr 29, 2024 | 2y |
| Madryn Asset Management, LP | GBNH Greenbrook TMS Inc. Common Shares | 13D/A | 61.7% | Apr 29, 2024 | 2y |
| Monte M. Brem | STEP StepStone Group Inc. | 13D/A | 47.4% | Apr 29, 2024 | 2y |
| Saba Capital Management, L.P. | ASA ASA Gold & Precious Metals Ltd | 13D/A | 16.87% | Apr 26, 2024 | 2y |
| Braden Ferrari | BTLN Brightline Interactive, Inc. | 13G/A | 5.4% | Apr 25, 2024 | 2y |
| Vikasati Partners LLC | CMCAF Piermont Valley Acquisition Corp | 13D | 56.37% | Apr 25, 2024 | 2y |
| Millennium Management LLC | MYGN Myriad Genetics Inc | 13G | 5% | Apr 25, 2024 | 2y |
| Rock Springs Capital Management LP | TVTX Travere Therapeutics, Inc. | 13G | 5.79% | Apr 25, 2024 | 2y |
| Phoenix Financial Ltd. | RMTHF Magic Software Enterprises Ltd | 13G | 5.01% | Apr 21, 2024 | 2y |
| BARD ASSOCIATES INC | LGL Lgl Group Inc | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Transform Wealth, LLC | AAPR Innovator ETFs Trust | 13G/A | 0% | Oct 5, 2022 | 2y |
| J. Mariner Kemper | UMBF Umb Financial Corp | 13D/A | 8.4% | Apr 28, 2024 | 2y |
| Shawn Devlin | BMRC Bank of Marin Bancorp | 13D/A | 3.5% | Apr 26, 2024 | 2y |
| GIC Private Ltd | UXIN Uxin Ltd | 13G/A | 6.85% | Apr 26, 2024 | 2y |
| Harrow, Inc. | ETON Eton Pharmaceuticals, Inc. | 13D/A | 0% | Apr 26, 2024 | 2y |
| Legion Partners Asset Management, LLC | NNBR Nn Inc | 13D/A | 9.9% | Apr 26, 2024 | 2y |